IP Library Assignment 059369/0242
Patent Assignment
Reel/Frame 059369/0242

Change of Name

Recorded: 2022-03-16 Pages: 4
Assignor
MNEMOSYNE PHARMACEUTICALS, INC.
Executed: 2015-09-30
Assignee
LUC THERAPEUTICS, INC.
400 TECHNOLOGY SQUARE, 10TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property (1)
Selective Octahydro-Cyclopenta[C]Pyrrole Negative Modulators of NR2B
Application: 17/398,622 →
Publication: US 2023/0012073
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 16, 2022
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.
To: MNEMOSYNE PHARMACEUTICALS, INC.
Reel/Frame 059369/0246 →
Change of Name Mar 16, 2022
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 059369/0256 →
Assignment of Assignor's Interest Jan 25, 2023
From: CADENT THERAPEUTICS, INC.
To: NOVARTIS AG
Reel/Frame 062486/0654 →